ARADIGM CORPORATION

Basic Information

3929 POINT EDEN WAY
HAYWARD, CA, 94545-3720

http://www.aradigm.com/

Company Profile

n/a

Additional Details

Field Value
DUNS: 792998783
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 21


  1. Evaluation of a new class of molecules for treating MRSA infective endocarditis

    Amount: $277,768.00

    DESCRIPTION (provided by applicant): Lung infections by Mycobacterium avium and Mycobacterium abscessus are increasing in incidence. Diseases caused by both Mycobacteria are common in patients with ch ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Amplified Attention Training (AAT) for the Treatment of Hemispatial Nelgect

    Amount: $339,824.00

    DESCRIPTION (provided by applicant): Although recurrent microaspiration of refluxed gastric fluid ( GER with microaspiration ) is suspected in the onset and course of many diseases of the lungs and ai ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Pulmonary delivery of nicotine using the AERx System

    Amount: $153,151.00

    DESCRIPTION (provided by applicant): Each year more Americans die from smoking-related diseases than from alcohol, AIDS, drug abuse, car accidents, fire, suicide and murder-combined. Smoking costs the ...

    SBIR Phase I 2005 Department of Health and Human Services
  4. Developing Human-Compatible Needleless Delivery Systems for Administering Bioscavengers

    Amount: $70,000.00

    The goals of this proposal are: 1) to identify a BChE formulation that will deliver the target systemic dose via the lungs; 2) to ensure that the integrity of the BChE protein is unaffected by the aer ...

    SBIR Phase I 2003 ArmyDepartment of DefenseDepartment of Defense
  5. PULMONARY GENE TRANSFER DELIVERY SYSTEMS

    Amount: $750,000.00

    DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, ...

    SBIR Phase II 1998 Department of Health and Human Services
  6. PULMONARY GENE TRANSFER DELIVERY SYSTEMS

    Amount: $99,750.00

    DESCRIPTION: (Adapted from the Applicant's Abstract). Inhaled gene products are desirable for chronic respiratory diseases with high morbidity and mortality, e.g. cystic fibrosis, emphysema, asthma, ...

    SBIR Phase I 1997 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government